IQVIA Holdings Inc. IQV

270.37 (4.65) (1.69%) as of 25 Sep
Market cap
$45.3B
P/E
33.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IQVIA Holdings Inc. (IQV) P/E ratio

As of 25 September 2026, IQVIA Holdings Inc. (IQV) trades at a P/E ratio of 33.3×. Over the past ten years it has ranged from 15.1× (February 2018) to 246× (September 2020); the current reading is higher than 51% of that period. That is in line with the Diagnostics & Research industry median of 33.9× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 28.4× 9.64%
FY2024 25.9× (16.62%)
FY2023 31.1× (11.39%)
FY2022 35.1× (37.20%)
FY2021 55.9× (54.47%)
FY2020 123× (22.16%)
FY2019 158× 72.36%
FY2018 91.5× 479.80%
FY2017 15.8× (64.93%)
FY2016 45.0× 106.40%

Quarterly

Period P/E ratio Change
Jun 2026 23.8× 13.44%
Mar 2026 21.0× (26.29%)
Dec 2025 28.4× 9.99%
Sep 2025 25.8× 14.46%
42 more quarters

Against its own ten years

Low 15.1× High 246×
Ten-year median 32.9×
Current reading's percentile 51

P/E ratio against peers

Company P/E ratio
NTRA Natera, Inc. compare n/m
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 24.8×
IQV IQVIA Holdings Inc. 33.3×
MTD Mettler-Toledo International, Inc. compare 33.9×
A Agilent Technologies, Inc. compare 33.9×
IDXX IDEXX Laboratories, Inc. compare 36.2×
ILMN Illumina, Inc. compare 50.4×
WAT Waters Corporation compare 108×
Diagnostics & Research industry median 33.9×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on IQV